Suriya Rehman – författare

This book introduces the principles and mechanisms of the biological synthesis of nanoparticles from microorganisms, including bacteria, fungi, viruses, algae, and protozoans. It also presents the medical applications of green nanoparticles, such as treating multidrug-resistant pathogens and cancer treatment.

This book introduces the principles and mechanisms of the biological synthesis of nanoparticles from microorganisms, including bacteria, fungi, viruses, algae, and protozoans. It also presents the medical applications of green nanoparticles, such as treating multidrug-resistant pathogens and cancer treatment.

This book aims to cover the applications of nanotechnology against human infectious diseases. The book also covers the state-of-the-art review of recent progress in biomimetic and bioengineered nanotherapies to treat infectious diseases.

This book aims to cover the applications of nanotechnology against human infectious diseases. The book also covers the state-of-the-art review of recent progress in biomimetic and bioengineered nanotherapies to treat infectious diseases.

This book reviews the use of nano-based drug delivery systems and biomaterials to enhance the immune system against infectious diseases. It focusses on the inbuilt immunoreactive properties of nanomaterials and the advancement in its engineering to modulate the immune system either via immune-stimulation or immunosuppression. The book further discusses the use of nanoparticle-based vaccines to improve vaccine efficacy, immunization strategies, and targeted delivery to achieve desired immune responses at the cellular level against infectious diseases.  Perhaps, book focusses on nanoscale diagnostics that offer new approaches for sensitive health monitoring that are potable and can guide the use of nanoscale therapies. This book explores the potential of immunomodulatory nanotechnologies, focusing not only on their benefits, but also on biocompatibility, and toxicity concerns, while highlighting promising innovations in Interferon-based immune therapies and addressing key challenges in achieving safe, scalable nanotech products. The book would encompass broad topics to attract the diverse specialty of physicians, health professionals, students, faculty, and researchers of nanotechnology, nanomedicine, infectious diseases, public health, immunology, bacteriology, virology, pathology, biotechnology, toxicology, and biomedical technology.